Finn Kortner

Title: The Innovative Journey of Finn Kortner

Introduction

Finn Kortner, based in Tromsø, Norway, is a notable inventor in the field of biotechnology. With three patents to his name, he has made significant contributions towards enhancing the immune systems of animals through innovative enzymatic treatments. His research is particularly focused on glucan products derived from yeast cells, showcasing his commitment to scientific advancements.

Latest Patents

Finn Kortner's latest patents include groundbreaking methodologies related to glucan treatment. One such patent details the enzyme treatment of glucans, specifically β-(1-6)-glucanase treatment of glucan extracted from yeast cells. This novel approach presents a glucan product that enhances the stimulation of host animal immune systems. Furthermore, the solubilization of yeast cell glucan not only extends its usefulness but also positions it as a viable adjuvant in immunostimulation processes for animals.

Career Highlights

Throughout his career, Finn Kortner has worked with well-respected institutions, contributing significantly to biotechnology. His tenure at Biotec Pharmacon ASA, a leading company in the biotechnology sector, has allowed him to collaborate on innovative projects that have practical applications in health and immunology. His commitment to advancing knowledge in enzymatic treatments highlights his dedication as a scientist and inventor.

Collaborations

Finn Kortner has partnered with distinguished colleagues such as Rolf Einar Engstad and Borre Robertsen. These collaborations have fostered a creative environment conducive to the development of innovative solutions in biotechnology. Working alongside such talented professionals has enabled them to push the boundaries of their research further.

Conclusion

Finn Kortner's contributions to the field of biotechnology, specifically through his patented inventions, exemplify the impact of innovation on animal health. With his extensive research on glucan treatments and collaborations with distinguished peers, he continues to pave the way for advancements in immunology, positioning himself as a key figure in the landscape of modern biotechnology.